The Leibniz Institute study published in Nature Communications reveals that age-dependent drops in phosphatidylcholine synthesis fragment mitochondrial networks in C. elegans, directly impairing fusion dynamics and metabolic flexibility. This worm model (small sample, genetic knockdown approach) shows rapid structural rescue upon choline repletion, yet lacks the rigor of mammalian RCTs and omits human longitudinal data on lipidomics. Prior work in Cell Metabolism (2019, n=120 mice) linked phosphatidylcholine depletion to cristae instability without addressing network connectivity, while a 2022 observational cohort in Aging Cell (n=450 humans) associated low choline intake with reduced VO2 max but could not establish causality due to confounding diet and exercise variables. The original coverage underplays how this lipid shift may intersect with NAD+ depletion pathways, creating a feed-forward loop that accelerates sarcopenia and cognitive decline beyond simple energy shortfalls. No conflicts of interest were declared by the FLI team, though broader longevity research often receives industry funding from supplement firms.